ESR1 and Alzheimer disease: The higher prevalence of AD in postmenary and older women relative to men has been linked to some potent neuroprotective effects of estrogen treatments mediated through estrogen receptor (ER)-activated transcriptional machineries and the signal transduction by membrane ERs (mERs) [7].